Purdue Pharma Canada:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Purdue Pharma Canada - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3444
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Purdue Pharma Canada, a subsidiary of Purdue Pharma LP is a research-based pharmaceutical company that offers services such as development, manufacturing and commercialization of medicines for patients and healthcare professionals. The company portfolio of products includes antiseptics, laxatives, decongestant, and prescription drugs, among others. It also provides medicines for pain, urinary incontinence, attention deficit hyperactivity disorder, respiratory disease, neurology, infection control, gastrointestinal disorders, psychiatry and others. Purdue Pharma conducts research for the discovery of new drugs, quality and clinical trials. The company works in partnership with other Purdue and Mundi companies globally for the development of new medicines. Purdue Pharma is headquartered in Pickering, Ontario, Canada.

Purdue Pharma Canada – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Purdue Pharma Canada, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Purdue Pharma Canada, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Purdue Pharma Canada, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Purdue Pharma Canada, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Purdue Pharma Canada, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Purdue Pharma Canada, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Purdue Pharma Canada Enters into Licensing Agreement with Klaria Pharma 10
Purdue Pharma (Canada) Enters into Licensing Agreement with BioDelivery Sciences International 11
Purdue Pharma Canada Enters into Licensing Agreement with Helsinn Group 12
Purdue Pharma Enters Into Licensing Agreement With Medical Developments 13
Helsinn Signs Licensing Agreement with Purdue Pharma Canada 14
Purdue Pharma Canada – Key Competitors 15
Purdue Pharma Canada – Key Employees 16
Purdue Pharma Canada – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Corporate Communications 18
Sep 25, 2017: David A. Pidduck Appointed President and CEO of Purdue Pharma (Canada) 18
Jul 05, 2017: Purdue Pharma appoints Dr. Tom Koutsavlis as new Vice President, Research and Development 19
May 30, 2017: Purdue Pharma appoints Carina Vassilieva as new Vice President, Human Resources 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Purdue Pharma Canada, Pharmaceuticals & Healthcare, Key Facts 2
Purdue Pharma Canada, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Purdue Pharma Canada, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Purdue Pharma Canada, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Purdue Pharma Canada, Deals By Therapy Area, 2012 to YTD 2018 8
Purdue Pharma Canada, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Purdue Pharma Canada Enters into Licensing Agreement with Klaria Pharma 10
Purdue Pharma (Canada) Enters into Licensing Agreement with BioDelivery Sciences International 11
Purdue Pharma Canada Enters into Licensing Agreement with Helsinn Group 12
Purdue Pharma Enters Into Licensing Agreement With Medical Developments 13
Helsinn Signs Licensing Agreement with Purdue Pharma Canada 14
Purdue Pharma Canada, Key Competitors 15
Purdue Pharma Canada, Key Employees 16

List of Figures
Purdue Pharma Canada, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Purdue Pharma Canada, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Purdue Pharma Canada, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Purdue Pharma Canada, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Purdue Pharma Canada, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Purdue Pharma Canada, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Purdue Pharma Canada, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Purdue Pharma Canada, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Purdue Pharma Canada:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EnergySolutions LLC:企業の戦略的SWOT分析
    EnergySolutions LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Renova Energia SA (RNEW11)-エネルギー分野:企業M&A・提携分析
    Summary Renova Energia S.A. (Renova Energia) is a renewable power generation company. It develops, implements and operates power generation projects based on renewable energy sources such as wind, small hydropower and solar; and sells electricity. It also undertakes activities related to manufacturi …
  • Mercy Health:企業の戦略的SWOT分析
    Mercy Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Mitsui Oil Exploration Co Ltd:企業の戦略的SWOT分析
    Mitsui Oil Exploration Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Chime Communications Limited:企業のM&A・事業提携・投資動向
    Chime Communications Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Chime Communications Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • TransAlta Corporation:企業の戦略・SWOT・財務分析
    TransAlta Corporation - Strategy, SWOT and Corporate Finance Report Summary TransAlta Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Syngene International Ltd (SYNGENE):製薬・医療:M&Aディール及び事業提携情報
    Summary Syngene International Ltd (Syngene), a subsidiary of Biocon Ltd, is a clinical research and manufacturing organisation. The organisation offers research, development and manufacturing programs. It provides discovery chemistry, discovery biology, large molecule development, safety assessment, …
  • PG&E Corporation:企業の戦略・SWOT・財務情報
    PG&E Corporation - Strategy, SWOT and Corporate Finance Report Summary PG&E Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Achema AB:企業の戦略的SWOT分析
    Achema AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Yiaco Medical Co:企業の戦略的SWOT分析
    Yiaco Medical Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Aldi Einkauf GmbH & Co oHG:企業の戦略・SWOT・財務分析
    Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report Summary Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Halliburton Co (HAL):企業の財務・戦略的SWOT分析
    Halliburton Co (HAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Highland Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Highland Therapeutics Inc (Highland) is a pharmaceutical company that develops and commercializes novel drugs. The company utilizes delexis platform, a drug delivery technology that allows for the nighttime delivery of medicines to provide a delay in the initial release of the active drug, f …
  • BlueScope Steel Ltd:企業の戦略・SWOT・財務分析
    BlueScope Steel Ltd - Strategy, SWOT and Corporate Finance Report Summary BlueScope Steel Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Daxor Corp (DXR):企業の財務・戦略的SWOT分析
    Daxor Corp (DXR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • National Institutes of Health:企業のM&A・事業提携・投資動向
    National Institutes of Health - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's National Institutes of Health Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Pakistan Water and Power Development Authority:企業の戦略的SWOT分析
    Pakistan Water and Power Development Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitor …
  • Davide Campari-Milano SpA:企業の戦略・SWOT・財務情報
    Davide Campari-Milano SpA - Strategy, SWOT and Corporate Finance Report Summary Davide Campari-Milano SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Bio-Rad Laboratories Inc (BIO):医療機器:M&Aディール及び事業提携情報
    Summary Bio-Rad Laboratories Inc (Bio-Rad) develops, manufactures and markets a range of products and systems for the life science research, healthcare, analytical chemistry and other markets. The company’s major products include reagents, apparatus, laboratory instruments, test systems, informatics …
  • Noble Energy Inc (NBL)-石油・ガス分野:企業M&A・提携分析
    Summary Noble Energy, Inc. (Noble Energy) is an independent energy company that explores for and produces crude oil, natural gas and natural gas liquids (NGLs). The company’s portfolio includes both US unconventional and global offshore conventional assets in various countries. Noble Energy has oper …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆